Dachaigh › Lymphoma Burkitt
Sgrùdaidhean clionaigeach Lymphoma Burkitt a’ fastadh anns na SA
Tha 63 sgrùdaidhean airson Lymphoma Burkitt a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX21 sgrùdaidhean
- Milwaukee, WI16 sgrùdaidhean
- Philadelphia, PA16 sgrùdaidhean
- New York City, NY14 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Cincinnati, OH12 sgrùdaidhean
- Atlanta, GA12 sgrùdaidhean
- Seattle, WA11 sgrùdadh
- Boston, MA10 sgrùdaidhean
- Durham, NC10 sgrùdaidhean
- Aurora, CO10 sgrùdaidhean
- Los Angeles, CA10 sgrùdaidhean
- Kansas City, MO10 sgrùdaidhean
- Orange, CA9 sgrùdaidhean
- Minneapolis, MN9 sgrùdaidhean
- Washington, DC9 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- Columbus, OH8 sgrùdaidhean
- Buffalo, NY8 sgrùdaidhean
- Portland, OR8 sgrùdaidhean
- San Francisco, CA8 sgrùdaidhean
- Nashville, TN8 sgrùdaidhean
- Ann Arbor, MI8 sgrùdaidhean
- Baltimore, MD8 sgrùdaidhean
- Tampa, FL7 sgrùdaidhean
- Dallas, TX7 sgrùdaidhean
- Providence, RI7 sgrùdaidhean
- Clifton, NJ7 sgrùdaidhean
- Salt Lake City, UT7 sgrùdaidhean
- San Antonio, TX7 sgrùdaidhean
- Oklahoma City, OK7 sgrùdaidhean
- Grand Rapids, MI7 sgrùdaidhean
- Greenburgh, NY7 sgrùdaidhean
- Jacksonville, FL7 sgrùdaidhean
- Cleveland, OH7 sgrùdaidhean
- Richmond, VA7 sgrùdaidhean
- Birmingham, AL7 sgrùdaidhean
- The Bronx, NY6 sgrùdaidhean
- Mountain View, CA6 sgrùdaidhean
- Oakland, CA6 sgrùdaidhean
Le stàit
- Alabama7 sgrùdaidhean
- Arizona7 sgrùdaidhean
- Arkansas5 sgrùdaidhean
- California20 sgrùdaidhean
- Colorado13 sgrùdaidhean
- Connecticut7 sgrùdaidhean
- Delaware7 sgrùdaidhean
- Florida15 sgrùdaidhean
- Georgia12 sgrùdaidhean
- Hawaii5 sgrùdaidhean
- Idaho6 sgrùdaidhean
- Illinois14 sgrùdaidhean
- Indiana6 sgrùdaidhean
- Iowa7 sgrùdaidhean
- Kansas6 sgrùdaidhean
- Kentucky5 sgrùdaidhean
- Louisiana4 sgrùdaidhean
- Maine4 sgrùdaidhean
- Maryland11 sgrùdadh
- Massachusetts10 sgrùdaidhean
- Michigan10 sgrùdaidhean
- Minnesota10 sgrùdaidhean
- Mississippi4 sgrùdaidhean
- Missouri8 sgrùdaidhean
- Nebraska5 sgrùdaidhean
- Nevada6 sgrùdaidhean
- New Hampshire4 sgrùdaidhean
- New Jersey8 sgrùdaidhean
- New Mexico3 sgrùdaidhean
- New York20 sgrùdaidhean
- North Carolina13 sgrùdaidhean
- North Dakota5 sgrùdaidhean
- Ohio17 sgrùdaidhean
- Oklahoma7 sgrùdaidhean
- Oregon8 sgrùdaidhean
- Pennsylvania18 sgrùdaidhean
- Rhode Island7 sgrùdaidhean
- Sgìre Cholumbia5 sgrùdaidhean
- South Carolina5 sgrùdaidhean
- South Dakota5 sgrùdaidhean
- Tennessee10 sgrùdaidhean
- Texas24 sgrùdaidhean
- Utah7 sgrùdaidhean
- Vermont3 sgrùdaidhean
- Virginia7 sgrùdaidhean
- Washington11 sgrùdadh
- West Virginia3 sgrùdaidhean
- Wisconsin17 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 2
366 Days – 46 Years · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06124157Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
A’ fastadhÌre 3
Aoisean 18 gu 39 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT03150693Blinatumomab Consolidation in Real World
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07117136Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05442515Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03739814Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03223610Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06144606Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A’ fastadhÌre 2
365 Days · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06317662Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07648264A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
A’ fastadhÌre 3
Aoisean 1 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07223021Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
A’ fastadhÌre 1/2
6 Months – 25 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06395103A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
A’ fastadhÌre 1
Aoisean 0 gu 18 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06173518UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
A’ fastadhÌre 1/2
31 Days – 30 Years · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04544592Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT03666000A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A’ fastadhÌre 2
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT04546399Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05389423Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A’ fastadhÌre 3
365 Days – 25 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03959085Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT06710418Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
A’ fastadhÌre 2
Aoisean 7 gu 25 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05082519AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT06137118AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06340737Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06287229Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
A’ fastadhÌre 2
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT03136146Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.